# Effect of Insulin Resistance Reducing Agents Pre and Post CABG on Post-operative Metabolic Status and Oxidative Stress

> **NCT02184507** · PHASE2 · COMPLETED · sponsor: **Mohammad Hassan Eftekhari** · enrollment: 92 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Supplement pre CABG
- **DIETARY_SUPPLEMENT:** Supplement post CABG
- **DIETARY_SUPPLEMENT:** Supplement pre and post CABG
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02184507
- **Lead sponsor:** Mohammad Hassan Eftekhari
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2014-03
- **Final completion:** 2014-07
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2014-10-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02184507

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02184507, "Effect of Insulin Resistance Reducing Agents Pre and Post CABG on Post-operative Metabolic Status and Oxidative Stress". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02184507. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*